Journey Medical Free Cash Flow (FCF) History (DERM)

Journey Medical reported −$24.1M in free cash flow for fiscal 2024, a decrease of $24.4M from the previous fiscal year, with a free cash flow margin of −43.76%.

View full Journey Medical company overview

Journey Medical free cash flow by year

Journey Medical annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20242024-12-31−$24.1M−$24.4M−43.76%
20232023-12-31$240,000$33.8M+0.40%
20222022-12-31−$33.5M−47.23%

Journey Medical free cash flow growth trends

Journey Medical's latest reported quarter, Q4 2023, generated −$16.5M in free cash flow, a decrease of $12.7M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Journey Medical filings at SEC.gov ↗